Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
160. Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity<br />
and specificity of single-field nonmydriatic monochromatic digital<br />
fundus photography with remote image interpretation for diabetic<br />
retinopathy screening: a comparison with ophthalmoscopy and standardized<br />
mydriatic color photography. Am J Ophthalmol.<br />
2002;134(2):204-13.<br />
161. Hernáez-Ortega MC, Soto-Pedre E, Vázquez JA, Gutiérrez MA, Asúa<br />
J. Estudio <strong>de</strong> la eficiencia <strong>de</strong> una cámara <strong>de</strong> retina no-midriática en el<br />
diagnóstico <strong>de</strong> retinopatía diabética. Rev Clin Esp. 1998;198(4):194-9.<br />
162. Younis N, Broadbent DM, Vora JP, Harding SP. Inci<strong>de</strong>nce of sightthreatening<br />
retinopathy in patients with type 2 diabetes in the Liverpool<br />
Diabetic Eye Study: a cohort study. Lancet. 2003;361(9353):195-200.<br />
163. Vázquez JA, Hernáez-Ortega MC, Miguel N, Soto E. Inci<strong>de</strong>ncia <strong>de</strong><br />
retinopatía diabética a partir <strong>de</strong> un programa <strong>de</strong> <strong>de</strong>spistaje en cámara<br />
no midriática empleado en pacientes diabéticos <strong>de</strong> la Comunidad<br />
Autónoma <strong>de</strong>l País Vasco (CAPV). Investigación comisionada. Informe<br />
nº. Osteba D-06-03. Vitoria-Gasteiz: Departamento <strong>de</strong> Sanidad.<br />
Gobierno Vasco; 2003.<br />
164. National Institute for Clinical Excellence. Clinical Gui<strong>de</strong>line F.Management<br />
of type 2 diabetes. Renal disease-prevention and early management.<br />
London: National Institute for Clinical Excellence; 2002.<br />
165. Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob<br />
M, et al. Systematic review on urine albumin testing for early <strong>de</strong>tection<br />
of diabetic complications. Health Technol Assess. 2005;9(30):<br />
iii-163.<br />
166. Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC. Angiotensin<br />
converting enzyme inhibitors and angiotensin II receptor antagonists<br />
for preventing the progression of diabetic kidney disease.<br />
Cochrane Database Syst Rev. 2006;(4):CD006257.<br />
167. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, An<strong>de</strong>rsen<br />
S, Arner P, et al. The effect of irbesartan on the <strong>de</strong>velopment of diabetic<br />
nephropathy in patients with type 2 diabetes. [see comments.].<br />
New England Journal of Medicine. 2001;345(12):870-8.<br />
168. Brenner BM, Cooper ME, <strong>de</strong> ZD, Keane WF, Mitch WE, Parving HH,<br />
et al. Effects of losartan on renal and cardiovascular outcomes in patients<br />
with type 2 diabetes and nephropathy. N Engl J Med.<br />
2001;345(12):861-9.<br />
144 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS
Change language